SecBot SecBot
6-K ·Filed Jul 20, 2026

ENLV

Enlivex Ltd.
BULLISH
Impact 7/10
Horizonweeks Processed3mo ago SEC0001213900-26-079409
Notable filing: 6-K
Actionable Insight ▲ Bullish

The massive discount to reported NAV could trigger a re-rating if the RAIN token market is liquid and the company can monetize its holdings. Traders should monitor RAIN token liquidity and any steps by management to close the NAV gap, such as share buybacks, token sales, or special dividends. The strong disconnect between treasury value and market cap is unsustainable in the medium term.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ENLV ▼ -95.21% at T+60d
LONG call ✗ call lost -95.21% · α vs SPY -100.05% · entry $4.64 → $0.2224
Entry = T+0 close
Jul 20, 2026
via day close
T+1d
+1.94%
call +1.94% · α +1.11%
$4.73
settled 3mo ago
T+5d
-9.48%
call -9.48% · α -9.06%
$4.20
settled 3mo ago
T+20d
-65.95%
call -65.95% · α -70.07%
$1.58
settled 2mo ago
T+60d
-95.21%
call -95.21% · α -100.05%
$0.2224
settled 14d ago

Price Chart

Loading chart...

Executive Summary

Enlivex disclosed a quarterly treasury update as of July 18, 2026, reporting net asset value per ordinary share of $66.16 and total RAIN token holdings valued at approximately $1.1 billion. The implied NAV-to-stock-price ratio is extreme (current market cap ~$79M vs. ~$1.1B in treasury assets), signaling a massive discount to treasury value.

Key Facts

  • NAV per ordinary share of $66.16 as of July 18, 2026.
  • Total treasury holdings of 79,550,593,122 RAIN tokens valued at approximately $1.1 billion.
  • Valuation uses the closing price of RAIN tokens per CoinMarketCap.
  • Company's market cap is ~$79M, implying an extreme discount to reported NAV.

Financial Impact

Treasury value of ~$1.1B vs. market cap of ~$79M; NAV per share of $66.16 vs. current stock price (implicitly ~$0.33). Discount to NAV is >99%.

net asset valuetreasury holdingsstock price / market cap

Risk Factors

  • RAIN token is highly volatile and illiquid; the $1.1B valuation may not be realizable in a sale.
  • Regulatory or market shifts in digital assets could impair treasury value.
  • Company's primary business is clinical-stage biotech with no revenue from operations; the treasury is the main asset.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-079409
Document: ea0298496-6k_enlivex.htm0001213900-26-079409
Document: 0001213900-26-079409-index-headers.html0001213900-26-079409
Document: 0001213900-26-079409-index.html0001213900-26-079409
Document: 0001213900-26-079409.txt0001213900-26-079409
22 reports for ENLV
Performance horizon
70% Hit rate @ T+5 7 of 10 directional calls Went positive at some point 8 of 10 best @ T+60▲ +90.97%Jul 28, 2026
Filters
Rows
Reports for ENLV — sortable, filterable
TypeNow
Oct 27, 2026
today
6-K
BEARISH ★ 6/10
$0.1734awaiting T+5—$2.70 (−1457.09%)
Oct 22, 2026
4d ago
6-K
NEUTRAL ★ 3/10
$0.1734awaiting T+5—$2.70 (+1457.09%)
Oct 22, 2026
4d ago
Press Release
NEUTRAL ★ 3/10
$0.1734awaiting T+5—$2.70 (+1457.09%)
Oct 19, 2026
8d ago
6-K
BEARISH ★ 6/10
$0.2070 $0.1704▲ +17.68%▲ +17.54%$2.70 (−1204.35%)
Oct 19, 2026
8d ago
Press Release
BEARISH ★ 6/10
$0.2070 $0.1704▲ +17.68%▲ +17.54%$2.70 (−1204.35%)
Sep 25, 2026
4w ago
6-K
NEUTRAL ★ 5/10
$0.5140 $0.3620▼ −29.57%▼ −30.78%$2.70 (+425.29%)
Sep 22, 2026
5w ago
6-K
BULLISH ★ 6/10
$0.6464 $0.4801▼ −25.73%▼ −24.54%$2.70 (+317.70%)
Aug 14, 2026
10w ago
EFFECT
NEUTRAL ★ 4/10
$1.58 $1.47▼ −6.96%▼ −5.59%$2.70 (+70.89%)
Jul 30, 2026
12w ago
6-K
BULLISH ★ 5/10
$1.95 $1.98▲ +1.54%▼ −2.08%$2.70 (+38.46%)
Jul 29, 2026
12w ago
6-K
NEUTRAL ★ 3/10
$2.25 $2.18▼ −3.11%▼ −8.64%$2.70 (+20.00%)
Showing 10 of 22

US Market Status

Market Closed — Opens Wed (16h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026